About N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide
N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide (PubChem CID 159450616) has the molecular formula C21H29FN4O4
and a molecular weight of 420.49 g/mol. Its IUPAC name is N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide.
Molecular Properties
| Compound Name | N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide |
| PubChem CID | 159450616 |
| Molecular Formula | C21H29FN4O4 |
| Molecular Weight | 420.49 g/mol |
| Exact Mass | 420.22 |
| IUPAC Name | N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide |
| SMILES | CN1CC[C@@H](C(=O)Cc2ccncc2F)N1C(=O)[C@H](CC1CCCC1)CN(O)C=O |
| InChI | InChI=1S/C21H29FN4O4/c1-24-9-7-19(20(28)11-16-6-8-23-12-18(16)22)26(24)21(29)17(13-25(30)14-27)10-15-4-2-3-5-15/h6,8,12,14-15,17,19,30H,2-5,7,9-11,13H2,1H3/t17-,19+/m1/s1 |
| InChIKey | LTIBPOZNIJZFJG-MJGOQNOKSA-N |
| XLogP | 1.82 |
| TPSA | 94.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 420.49 |
| LogP ≤ 5 | 1.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide?
The IUPAC name of N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide (CID 159450616) is N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide.
What is the SMILES notation for N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide?
The canonical SMILES for N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide is CN1CC[C@@H](C(=O)Cc2ccncc2F)N1C(=O)[C@H](CC1CCCC1)CN(O)C=O.
What is the InChIKey of N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide?
The InChIKey is LTIBPOZNIJZFJG-MJGOQNOKSA-N. The full InChI is InChI=1S/C21H29FN4O4/c1-24-9-7-19(20(28)11-16-6-8-23-12-18(16)22)26(24)21(29)17(13-25(30)14-27)10-15-4-2-3-5-15/h6,8,12,14-15,17,19,30H,2-5,7,9-11,13H2,1H3/t17-,19+/m1/s1.
What are the key properties of N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide?
N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide has a molecular weight of 420.49 g/mol, XLogP of 1.82, 9 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R)-2-(cyclopentylmethyl)-3-[(5S)-5-[2-(3-fluoro-4-pyridinyl)acetyl]-2-methylpyrazolidin-1-yl]-3-oxopropyl]-N-hydroxyformamide is sourced from PubChem (CID 159450616), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).